Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) Kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback